Windtree Therapeutics - WINT Year-over-year earnings per share growth for the last twelve months

Windtree Therapeutics (WINT) develops innovative therapies for heart failure and cardiogenic shock. The quarterly earnings per share growth on the GURU.Markets daily chart reflects the development trend, where 0.00 indicates the current level. Management is focused on bringing critical drugs to market. Low geopolitical pressure and the humanitarian status of medicine ensure stable operations within Western legal frameworks.

windtreetx.com (WINT) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 09/06/2025

Windtree Therapeutics (WINT) - metric breakdowns and financial figures

- share price and consensus valuation forecast:

Stock Quotes windtreetx.com|WINT - Analyst Forecast Prices

- issuer market value details:

Market Value Windtree|WINT - Value Adjusted for Debt and Cash

- book capitalization data:

Book Value per Share Windtree Therapeutics|WINT - Total Stockholders' Equity|Market Capitalization to Book Value Ratio windtreetx.com|WINT - Company Assets

- business debt structure and liquidity details:

Total Debt to Equity Ratio Windtree Therapeutics|WINT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio windtreetx.com|WINT - Company Cumulative Indebtedness|Debts to Book Capitalization Windtree|WINT - Company Long-Term Loans and Borrowings|Company Short-Term Debts Windtree Therapeutics|Quick Liquidity windtreetx.com

- earnings and valuation multiples indicators:

WINT - Final Profit|Projected Future Earnings Windtree Therapeutics|WINT - P/E Multiple|Future Price to Earnings windtreetx.com|WINT - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Windtree|WINT - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Windtree Therapeutics|WINT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months windtreetx.com|WINT - Net earnings per one share growth for the current year|Earnings growth forecast for next year Windtree Therapeutics

Fundamental company valuation:Windtree Therapeutics Inc. - WINT

Finished products of Windtree Therapeutics, Inc.

To minimize risks amid uncertainty, it is crucial for investors to track the dynamics of net income per share, which measures the real rate of change in profitability relative to previous periods. Analyzing the quarterly earnings per share growth rate allows for the identification of a gap between market expectations and the actual efficiency of Windtree Therapeutics (WINT), whose cardiology development costs are frequently covered through equity issuances.

Who Windtree Therapeutics competes with

REGN (Regeneron) - Year-over-year net earnings per share growth for the last 12 months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Lantheus Medical Imaging|MLYS: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HTFL|KMTS - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth ESPR (Esperion)|Amarin Corporation (AMRN) - Earnings per share growth in annualized terms for the last twelve months|AVR: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months TNYA (Tenaya Therapeutics)|CVRX (CVRx, Inc.) - Year-over-year net earnings per share growth for the last 12 months|MIST: Year-over-year earnings per share growth rate for the last twelve months|CRDL (Cardiol Therapeutics Inc) - Quarterly EPS earnings growth|BEAT: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TENX|ADGM - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months BioCardia, Inc. BCDA|Year-over-year earnings per one share growth for the last 12 months VTAK|ARCA Bio - Quarterly EPS earnings growth|ACST - Quarterly EPS earnings growth|Aerovate (AVTE) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months VERV (Verve Therapeutics, Inc.)